FDA panel unanimously backs Regeneron eye drug
Friday, June 17, 2011 - 14:00
in Health & Medicine
(AP) -- A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.